European Archives - Page 686 of 899 - European Medical Journal

Neurodegeneration Biomarkers for Diagnosis of Alzheimer’s and MND

26 July, 2017 – A portfolio of CSF biomarkers corresponding to different stages of the neurodegenerative process aids diagnosis of Alzheimer’s disease…

Comprehensive Serological Diagnostics in Neurology

26 July, 2017 – Neurological disorders, including memory deficits, psychosis and seizures, can be caused by underlying autoimmune reactions.

EMJ Rheumatology 3.1 2016

Welcome to this year’s edition of EMJ Rheumatology, packed full of exciting news and developments from throughout the past year.

ANTABIO Awarded Up to $8.9M from CARB-X to Accelerate the Development of Its New Treatment For Chronic Infections in Cystic Fibrosis Patients

Labège, France, 25 July, 2017 – Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs…

Orchard Therapeutics Announces That OTL-101 Has Received a Rare Paediatric Disease Designation

London, UK, 24 July, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company dedicated to bringing transformative…

Infertility: Century-Old Procedure Offers New Hope

OLD imaging techniques give new hope for infertile couples trying to conceive. Infertility affects a substantial proportion of the world’s population…

3D Printed Scaffolds Restore Ovary Function in Infertile Mice

INFERTILE mice, that have been surgically sterilised, have given birth to healthy offspring with the aid of three-dimensional (3D) printing functioning…

A Haemophilia Hero Scales Everest

On 22nd May 2017, at 9:59 am, a man from Denver, Colorado, USA achieved what many in the global bleeding disorders community never thought possible: he…

Broccoli Sprout Extract Improves Type 2 Diabetics Fasting Glucose Levels

SULFORAPHANE, a compound found in broccoli and other cruciferous vegetables, significantly improved fasting blood glucose levels in obese adults with…

Type 2 Diabetes Drug Reduces Cardiovascular Disease Risk

CANAGLIFLOZIN, a drug currently prescribed for lowering blood sugar in patients with Type 2 diabetes, has also been found to lower the risk of…